Premium
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy
Author(s) -
Tomasoni Daniele,
Bai Francesca,
Castoldi Roberto,
Barbanotti Diletta,
Falcinella Camilla,
Mulè Giovanni,
Mondatore Debora,
Tavelli Alessandro,
Vegni Elena,
Marchetti Giulia,
d'Arminio Monforte Antonella
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26459
Subject(s) - depression (economics) , anxiety , hospital anxiety and depression scale , cross sectional study , covid-19 , pathological , medicine , disease , persistence (discontinuity) , coronavirus , psychiatry , infectious disease (medical specialty) , pathology , geotechnical engineering , engineering , economics , macroeconomics
Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID‐19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS‐A/D). 30% of patients displayed pathological HADS‐A/D, 52.4% showed persistent symptoms. Pathological patients with HADS‐A/D more commonly reported symptom persistence, even after adjustment for age, gender, and disease severity. Psychological assessments should be encouraged in COVID‐19 patients' follow‐up.